Revue francophone des laboratoires : RFL最新文献

{"title":"Risque de troubles digestifs en associant anti-acides et agonistes du GLP-1","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76703-4","DOIUrl":"10.1016/S1773-035X(26)76703-4","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 7"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Traitement anti-obésité : la FDA approuve “en express” une nouvelle entité moléculaire","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76707-1","DOIUrl":"10.1016/S1773-035X(26)76707-1","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 10"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148656461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risque de troubles digestifs en associant anti-acides et agonistes du GLP-1","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76703-4","DOIUrl":"10.1016/S1773-035X(26)76703-4","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 7"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148657153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Suivi thérapeutique pharmacologique: Pour la personnalisation des traitements médicamenteux","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76710-1","DOIUrl":"10.1016/S1773-035X(26)76710-1","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 12"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Du nouveau pour les articulations et le psoriasis","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76712-5","DOIUrl":"10.1016/S1773-035X(26)76712-5","url":null,"abstract":"<div><h3>Résumé</h3><div><strong>Un arrêté au <em>Journal officiel</em> du ministère de la Santé signale la spécialité Fubelv® (étanercept, laboratoire Biogaran), intéressante à plusieurs titres</strong>.</div></div>","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 13"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Caractérisation génomique d’une souche de Mycobacterium tuberculosis multirésistante isolée chez un bovin à Djibouti","authors":"Samia Kahsay Hagos,&nbsp;Chloé Dupont,&nbsp;Hasna Said Mohamed,&nbsp;Christian Carrière,&nbsp;Guilhem Conquet,&nbsp;Bastien Baud,&nbsp;Hamadoun Garba,&nbsp;Mohamed Osman Hassan,&nbsp;Mohamed H. Aboubaker,&nbsp;Sylvain Godreuil","doi":"10.1016/S1773-035X(26)76724-1","DOIUrl":"10.1016/S1773-035X(26)76724-1","url":null,"abstract":"<div><h3>Résumé</h3><div>Nous présentons ici la première étude utilisant des méthodes microbiologiques et génétiques pour analyser la tuberculose bovine (bTB) dans des carcasses d’abattoir, ainsi que la première description d’une infection à <em>Mycobacterium tuberculosis</em> (MTB) multirésistant (MTB-MDR) (MDR pour <em>Multi-Drug Resistant</em>) chez des bovins à Djibouti. La mise en évidence de MTB-MDR chez les bovins soulève d’importantes préoccupations quant à une possible transmission bidirectionnelle entre l’humain et l’animal. Cette situation pourrait compliquer les efforts de lutte contre la tuberculose en favorisant l’introduction de souches résistantes dans la population humaine, par contact direct ou par la consommation de produits d’origine animale contaminés. En outre, les bovins pourraient devenir des réservoirs de souches MTB-MDR, contribuant ainsi à l’amplification et à la propagation de ces isolats en l’absence de mesures adéquates de détection et de contrôle.</div></div><div><h3>Abstract</h3><div>Here, we present the first study to apply microbiological and genetic approaches to investigate bovine tuberculosis (bTB) in slaughterhouse carcasses, as well as the first report of Mycobacterium tuberculosis infection in cattle in Djibouti. The identification of multidrug-resistant (MDR) M. tuberculosis in cattle raises serious concerns regarding potential bidirectional transmission between humans and animals. Such transmission could complicate tuberculosis control efforts by facilitating the introduction of drug-resistant strains into the human population through direct contact or the consumption of contaminated animal products. Moreover, cattle may act as reservoirs for drug-resistant TB strains, thereby contributing to the amplification and dissemination of resistance genes in the absence of adequate detection and control measures.</div></div>","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Pages 43-45"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Un myélome multiple atypique à ne pas prendre à la légère !","authors":"Marine Jaillard,&nbsp;Julie Milandri,&nbsp;Magali Dechomet","doi":"10.1016/S1773-035X(26)76726-5","DOIUrl":"10.1016/S1773-035X(26)76726-5","url":null,"abstract":"<div><h3>Résumé</h3><div>Le myélome multiple (MM) à chaînes légères libres est une gammapathie monoclonale représentant 15 % des myélomes multiples. Les plus fréquents sont les myélomes à IgG (56 %) et les myélomes à IgA (26 %). L’âge moyen au diagnostic est de 65 ans. D’après la littérature, seulement 2 % des cas sont des patients de moins de 40 ans et 0,2 % des cas sont des patients de moins de 30 ans. Ce cas retrace l’histoire d’un patient de 29 ans, atteint d’un myélome à chaînes légères libres kappa à présentation atypique. Le diagnostic a été réalisé aux urgences, après adressage par le médecin traitant, et le patient a été pris en charge sans délai dans le service d’hématologie clinique.</div></div><div><h3>Abstract</h3><div>Free light chain multiple myeloma (MM) is a monoclonal gammopathy representing 15 % of multiple myelomas. The most common are IgG myelomas (56 %) and IgA myelomas (26 %). The average age at diagnosis is around 65 years. According to the literature, only 2 % of cases are patients aged under 40 and 0,2 % of cases are patients under 30. We report the case of a 29-year-old patient diagnosed with atypical kappa free light chain myeloma. The diagnosis was established in the emergency department following referral by the general practitioner, and the patient was immediately managed to the clinical hematology department for treatment.</div></div>","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Pages 50-55"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Médecine de la femme : un terme nouveau pour le SO(M)PK","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76717-4","DOIUrl":"10.1016/S1773-035X(26)76717-4","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 17"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Traitement anti-obésité : la FDA approuve “en express” une nouvelle entité moléculaire","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76707-1","DOIUrl":"10.1016/S1773-035X(26)76707-1","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 10"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"L’artéméther-luméfantrine,: un nouveau traitement qui sauvera des nourrissons","authors":"Jean-Marie Manus","doi":"10.1016/S1773-035X(26)76708-3","DOIUrl":"10.1016/S1773-035X(26)76708-3","url":null,"abstract":"","PeriodicalId":74728,"journal":{"name":"Revue francophone des laboratoires : RFL","volume":"2026 584","pages":"Page 11"},"PeriodicalIF":0.0,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148661496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}